Author: Stephen M Kissler; Christine Tedijanto; Edward Goldstein; Yonatan H. Grad; Marc Lipsitch
Title: Projecting the transmission dynamics of SARS-CoV-2 through the post-pandemic period Document date: 2020_3_6
ID: f4hj35dr_52
Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.04.20031112 doi: medRxiv preprint Table S4 . Peak simulated SARS-CoV-2 epidemic sizes, in units of percent influenza-like illness (ILI) x percent positive laboratory tests, by year for a representative set of cross immunities, immunity durations, and establishment times. Percent ILI is measured as the population-weighted proportion of vis.....
Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.04.20031112 doi: medRxiv preprint Table S4 . Peak simulated SARS-CoV-2 epidemic sizes, in units of percent influenza-like illness (ILI) x percent positive laboratory tests, by year for a representative set of cross immunities, immunity durations, and establishment times. Percent ILI is measured as the population-weighted proportion of visits to sentinel providers that were associated with influenza symptoms. The seasonality factor represents the amount of seasonal variation in the SARS-CoV-2 R0 relative to the other human betacoronaviruses. A seasonality factor of 1 indicates equal seasonal variation in R0 for SARS-CoV-2 as for the other human betacoronaviruses. Chi3X represents the degree of crossimmunity induced by infection with SARS-CoV-2 against OC43 and HKU1 and ChiX3 represents the degree of crossimmunity induced by OC43 or HKU1 infection against SARS-CoV-2. The establishment times correspond to: Winterweek 4 (early February); Spring -week 16 (late April); Summer -week 28 (mid July); Autumn -week 40 (early October). Darker shading corresponds to higher peak sizes.
Search related documents:
Co phrase search for related documents- cross immunity and establishment time immunity duration: 1, 2
- cross immunity and immunity duration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- cross immunity and peak size: 1, 2
- cross immunity and R0 seasonal variation: 1, 2, 3, 4, 5, 6
- cross immunity and representative set: 1, 2, 3, 4, 5, 6, 7
- cross immunity and seasonal variation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- cross immunity and seasonality factor: 1, 2, 3, 4, 5
- epidemic size and high peak size: 1
- epidemic size and immunity duration: 1
- epidemic size and peak size: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57
- epidemic size and SARS epidemic size: 1, 2, 3, 4
- epidemic size and seasonal variation: 1
- establishment time and immunity duration: 1, 2
- establishment time and peak size: 1, 2
- establishment time and R0 seasonal variation: 1
Co phrase search for related documents, hyperlinks ordered by date